US2005153891A1PendingUtilityA1
Viral protein binding compositions and methods
Est. expiryJul 16, 2019(expired)· nominal 20-yr term from priority
Inventors:Stacey EfstathiouAntonio AlcamiChristopher Marc ParryVincent Peter SmithJoão Pedro Monteiro E Louro Machado De Simas
G01N 33/6863C07K 14/005A61P 33/00C12N 2710/16022A61P 37/02C12N 2710/14143A61K 38/00A61P 31/12Y10S530/826
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A pharmaceutical composition comprises M3 protein as encoded by virus MHV 68, or a homologue of said M3 protein, for use in binding to a chemokine or a chemokine analogue in vivo, or to block binding of chemokines to corresponding cell surface receptors in vivo, to produce an immunomodulatory effect, or to bind to a chemokine analogue present in a virus or parasite to block its entry into cells.
Claims
exact text as granted — not AI-modified1 . A pharmaceutical composition comprising M3 protein as encoded by virus MHV 68, or a homologue of said M3 protein, for use in binding to a chemokine or a chemokine analogue in vivo, or in blocking binding of a chemokine to a corresponding cell surface receptor in vivo, to produce an immunomodulatory effect.
2 . A composition according to claim 1 , for use in producing an anti-inflammatory effect.
3 . A pharmaceutical composition comprising M3 protein as encoded by virus MHV 68 or a homologue of said M3 protein, for use in binding to a chemokine analogue present in a virus or parasite to reduce or block entry of said virus or parasite into cells.
4 . A pharmaceutical composition comprising (a) M3 protein as encoded by virus MHV 68 or a homologue of said M3 protein and (b) an additional immunosuppressant or anti-inflammatory substance.
5 . A test kit comprising M3 protein or a homologue thereof and a labelled or immobilised reactant, for detecting or measuring a chemokine, chemokine analogue, or chemokine receptor in vitro.
6 . A test kit according to claim 5 , comprising said M3 protein or a homologue thereof labelled with a detectable label.
7 . A test kit according to claim 5 , wherein said M3 protein or homologue thereof is immobilised on a solid support.
8 . A composition comprising a polypeptide homologue of M3 protein (other than M3 protein itself) which can bind to a chemokine or chemokine analogue.
9 . A composition according to claim 8 , comprising a coupling product of M3 protein or homologue thereof with another substance, or a fusion protein comprising an M3 polypeptide sequence or homologue thereof fused to a polypeptide sequence of other origin.
10 . A composition according to claim 8 , wherein said M3 protein or homologue thereof is coupled to a detectable label.
11 . A polynucleotide having a sequence encoding either (a) a homologue of M3, or (b) a fusion polypeptide comprising M3 protein or a homologue thereof, fused to a polypeptide sequence of other origin.
12 . A polynucleotide according to claim 11 , comprising an expression cassette wherein said sequence encoding (a) or (b) is operably associated with a tissue specific or a constitutive promoter.
13 . A polynucleotide according to claim 11 , wherein said sequence encoding (a) or (b) forms part of a viral vector or an expression plasmid.
14 . A method of treatment to produce an anti-inflammatory effect which comprises administering to a subject to be treated a pharmaceutical composition of claim 1 , or comprising an expression vector encoding and capable of expressing said M3 protein or protein homologue.
15 . A method of treatment to reduce or block entry of a virus or parasite into cells of a subject infected with said virus of parasite, which comprises administering the pharmaceutical composition of claim 3 , or an expression vector expressing said M3 protein or protein homologue, to said subject to bind to a chemokine analogue present in said virus or parasite.
16 . A method of detecting a substance that comprises a chemokine or chemokine analogue, which comprises contacting a sample possibly comprising said substance to be tested with a reagent comprising M3 protein as encoded by virus MHV 68, or a homologue of said M3 protein, thereby to bind said chemokine or chemokine analogue.Join the waitlist — get patent alerts
Track US2005153891A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.